March 31, 2026
⚑ Important
Regulation
MHLW Issues Final Implementation Guidelines for CBN Specified Drug Classification
The Ministry of Health, Labour and Welfare published comprehensive enforcement guidelines for CBN's Specified Drug designation taking effect June 1, 2026. The 47-page document clarifies inventory disposal requirements, import permit cancellation procedures, and establishes a 60-day grace period for existing CBN products in distribution channels. Importers must submit detailed inventory reports by April 30 and provide certificates of destruction for unsold CBN products by July 31, 2026.
April 1, 2026
Market
Japanese CBG Market Projected to Reach ¥2.8 Billion by 2027
Market research firm Cannabis Analytics Japan released its Q1 2026 report projecting rapid CBG market expansion as brands pivot from CBN products. The study indicates CBG oil and isolate imports increased 340% quarter-over-quarter, with wellness applications driving consumer adoption. Tokyo-based retailers report CBG products now comprise 23% of cannabinoid sales, up from 8% in December 2025.
📰
Cannabis Analytics Japan
·
cannabisanalytics.jp
April 2, 2026
⚑ Important
Regulation
Tokyo Customs Intensifies THC Screening with New Detection Equipment
Tokyo Customs announced deployment of advanced LC-MS/MS equipment capable of detecting THC residues at 0.001% levels, significantly below Japan's zero-tolerance threshold. The enhanced screening targets CBD isolate shipments following recent detections of trace THC in products previously certified as compliant. Import clearance times for cannabinoid products are expected to increase by 3-5 business days as testing protocols expand.
📰
Japan Customs
·
customs.go.jp
April 2, 2026
Science
University of Tokyo Study Identifies Optimal CBG Extraction Methods for Import Compliance
Researchers at the University of Tokyo's Graduate School of Pharmaceutical Sciences published findings on CBG extraction techniques that minimize THC cross-contamination. The peer-reviewed study in the Journal of Natural Products demonstrates that specific CO2 extraction parameters can achieve CBG purity levels exceeding 99.8% while maintaining undetectable THC residues. The research provides technical guidance for overseas manufacturers targeting Japanese market entry.
April 3, 2026
Business
Major Japanese Pharmaceutical Distributor Enters CBG Supply Chain Partnership
Osaka-based pharmaceutical distributor Daiichi Yakuhin announced a strategic partnership with European CBG manufacturers to establish Japan-compliant supply chains. The agreement includes dedicated testing facilities in Yokohama and streamlined import procedures for verified CBG isolate and distillate products. Industry analysts view this as a significant validation of CBG's commercial potential in Japan's regulated cannabinoid market.
📰
Nikkei Biotech
·
nikkei.com